Table 1.
AS patient(n=10) | Control (n=10) | |
---|---|---|
Age median (range) years: | 47 (18–58) | 45 (28–57) |
Sex, %male: | 90 | 90 |
Disease duration median (range) years: | 15 (2–32) | NA |
HLA-B27, number positive: | 9 | 0 |
BASDAI, median (range): | 3.2 (0–5.4) | N.A. |
Arthritis meds: | ||
NSAIDs: | 6 | 1* |
Methotrexate: | 2 | 0 |
TNF-blockers: | 5 | 0 |
Other: | sulfasalazine (1) | allopurinol (1) |
glucosamine (1) | glucosamine (1) | |
fosamax (1) |
1 Control was taking 325 mg aspirin for history of myocardial infarction. Not included above were 3 other controls taking anti-platelet doses of aspirin (81 mg).
NA: not applicable, ND: not determined, BASDAI: Bath ankylosing spondylitis disease activity score, NSAIDS: non-steroidal anti-inflammatories, TNF: Tumor necrosis factor. 6 patients were on disease modifying anti-rheumatic drugs (DMARDS: Methotrexate and/or TNF blockers).